Dr. Reddy’s Laboratories has informed that the United States Food & Drug Administration (USFDA) today completed a routine Good Manufacturing Practice (GMP) inspection at its R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad. The inspection was conducted from 16th September to 20th September, 2024. The inspection closed with zero observations.
The above information is a part of company’s filings submitted to BSE.